| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3852656 | American Journal of Kidney Diseases | 2007 | 9 Pages |
Abstract
Overactivation of basal P70S6K in PBMCs from renal transplant recipients appears to be associated with the presence of Kaposi sarcoma dermal lesions; conversely, kinase inhibition is linked to regression of skin cancer lesions. Thus, monitoring P70S6K phosphorylation can help predict and monitor the biological effectiveness of rapamycin in renal transplant recipients with Kaposi sarcoma and possibly adjust the biologically active doses of the mTOR inhibitor.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Salvatore MD, Annalisa MD, Elena PhD, Loreto MD, Paolo F. MD,